| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | Apr 1, 2024 | Gain Therapeutics, Inc. | Director | Buy | 95.0 | +30,000 | 100.00% | ✗ | $115.8K |
| Jan 7, 2013 | Jan 7, 2013 | Theriva Biologics, Inc. | CEO | Buy | 90.0 | +2,900 | 38.67% | ✗ | $506.5 |
| Jan 3, 2013 | Jan 4, 2013 | Theriva Biologics, Inc. | CEO | Buy | 90.0 | +2,000 | 36.36% | ✗ | $3.4K |
| Jan 2, 2013 | Jan 3, 2013 | Theriva Biologics, Inc. | CEO | Buy | 90.0 | +5,500 | 100.00% | ✗ | $9.7K |